Singapore's multibillion dollar gamble

How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedi...

Descripción completa

Detalles Bibliográficos
Autor principal: Van Epps, Heather L.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2006
Materias:
News Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121196/
https://www.ncbi.nlm.nih.gov/pubmed/16704968
http://dx.doi.org/10.1084/jem.20060895
Descripción
Sumario:How does a country one-fourth the size of Rhode Island with little history in biomedical science become one of the world's biomedical research giants? The answer: with a pile of money and a large dose of chutzpah. Since 2000, Singapore has dumped more than US$2 billion into developing a biomedical research industry—from scratch. Is the gamble paying off?

Ejemplares similares